Vimarsana
Biggest News Aggregation in the World

Page 2 - Jonil Rutter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jonil Rutter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jonil Rutter Today - Breaking & Trending Today

Rare disease consortium is good news for NC gene therapy companies - Vimarsana News

Rare disease consortium is good news for NC gene therapy companies

RESEARCH TRIANGLE PARK - The nearly 30 million Americans who suffer from rare diseases have received some good news. The National Institutes of Health, the U.S.

Gene Therapy Consortium Provides New Hope for Rare Disease Suffers | North Carolina Biotechnology Center - Vimarsana News

Gene Therapy Consortium Provides New Hope for Rare Disease Suffers | North Carolina Biotechnology Center

A new national public/private consortium designed to boost the development of gene therapies also holds promise for North Carolina, as a major global leader in cell and gene therapies.

NIH, FDA and 15 private organizations join forces to increase effective gene therapies for rare diseases - Vimarsana News

NIH, FDA and 15 private organizations join forces to increase effective gene therapies for rare diseases

While there are approximately 7,000 rare diseases, only two heritable diseases currently have FDA-approved gene therapies.

Source: nih.gov
NIH, FDA and 15 private organizations join forces to increase effective gene therapies for rare diseases - Vimarsana News

NIH, FDA and 15 private organizations join forces to increase effective gene therapies for rare diseases

The National Institutes of Health, U.S. Food and Drug Administration, 10 pharmaceutical companies and five non-profit organizations have partnered to

Health care costs for people with rare diseases have been underestimated, study shows - Vimarsana News

Health care costs for people with rare diseases have been underestimated, study shows

A new, retrospective study of medical and insurance records indicates health care costs for people with a rare disease have been underestimated and are three to five times greater than the costs for people without a rare disease.